Abeona Therapeutics Inc (ABEO)

Abeona Therapeutics Inc (ABEO) 財務データ

*すべての数値は百万単位です

期間終了日	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	-	-	3.50	-	0.068
Operating Expenses	16.54% 13.21	11.33	14.05	12.04	13.00
Interest Income/Expense	3.81% 0.109	0.105	0.103	0.101	0.178
Benefits Costs and Expenses	200.00% -41.10	41.10	-	-	-39.92
Costs And Expenses	16.54% 13.21	11.33	14.05	12.04	13.00
Depreciation and Amortization	0.00% 0.50	0.50	0.60	0.70	0.80
Operating Income/Loss	16.54% -13.21	-11.33	-10.55	-12.04	-12.94
Nonoperating Income/Loss	92.79% 0.214	0.111	2.215	0.403	-
Income/Loss From Continuing Operations Before Tax	447.22% 41.10	-11.84	3.50	-9.107	39.98
Income/Loss From Continuing Operations After Tax	40.17% -16.59	-11.84	-16.65	-9.107	-1.126
Net Income/Loss	40.17% -16.59	-11.84	-16.65	-9.107	-1.126
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	94.20% 1.4379	24.80	18.02	16.90	1.8516
Diluted Average Shares	94.20% 1.4379	24.80	18.02	-0.5538	-
Basic Earnings Per Share	33.33% -0.64	-0.48	0.92	-0.54	1.52
Diluted Earnings Per Share	33.33% -0.64	-0.48	0.92	0.56	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-